Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 3 | Journal of Translational Medicine

Figure 3

From: A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer

Figure 3

Survival analyses of all patients with available age or tumor stage information using the eight-lncRNA signature. a Kaplan–Meier survival curves for younger patients with NSCLC (age ≤65, n = 337). b Kaplan–Meier survival curves for elder patients with NSCLC (age >65, n = 226). c Survival prediction in early stage patients: Kaplan–Meier survival curves for all patients with stage I and II (n = 165). d Survival prediction in late stage patients: Kaplan–Meier survival curves for all patients with stage III and IV (n = 31).

Back to article page